LONDON--(BUSINESS WIRE)-- The Vertex Foundation, a nonprofit charitable foundation, today announced a €1 million donation to Ronald McDonald House Charities (RMHC) to support the construction of a Ronald McDonald House at the new children’s hospital in Dublin, Ireland.

The donation will support the building of a 53-bedroom Ronald McDonald House at the new children’s hospital, which will provide a home for families with seriously ill children.

“We are delighted to support Ronald McDonald House Charities as they create this amazing new facility that will provide the highest level of support to families from across Ireland,” said Michael Parini, Chairman of the Vertex Foundation and Executive Vice President and Chief Administrative, Legal and Business Development Officer at Vertex. “It’s so important for a child’s family to be close by when they are in the hospital, and this House will provide that opportunity to parents and families when they need it most.”

“This extraordinary gift from the Vertex Foundation will help us provide family-centered care and spaces for families so they can be together during a critical time in their lives,” said Marian Carroll, CEO (Volunteer), RMHC Ireland. “We are grateful for their recognition and support of our mission.”

About the Vertex Foundation

The Vertex Foundation is a nonprofit charitable foundation. It seeks to improve the lives of people with serious diseases and in its communities through education, innovation and health programs. Established in 2017, the Foundation is a long-term source of charitable giving and is part of Vertex Pharmaceuticals’ corporate giving commitment. To learn more about the Vertex Foundation, visit https://www.vrtx.com/responsibility/vertex-foundation.

About Vertex

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — a rare, life-threatening genetic disease — and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational small molecule medicines in other serious diseases where it has deep insight into causal human biology, including pain, alpha-1 antitrypsin deficiency and APOL1-mediated kidney diseases. In addition, Vertex has a rapidly expanding pipeline of genetic and cell therapies for diseases such as sickle cell disease, beta thalassemia, Duchenne muscular dystrophy and type 1 diabetes mellitus.

Founded in 1989 in Cambridge, Mass., Vertex's global headquarters is now located in Boston's Innovation District and its international headquarters is in London, UK. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia and Latin America. Vertex is consistently recognized as one of the industry's top places to work, including 10 consecutive years on Science magazine's Top Employers list and top five on the 2019 Best Employers for Diversity list by Forbes.

About RMHC

Ronald McDonald House Charities® (RMHC®), is a non-profit, 501(c)(3) corporation that creates, finds, and supports programs that directly improve the health and well-being of children and their families. Through a global network of over 260 Chapters in 65 countries and regions, RMHC enables, facilitates and supports family-centered care through three core programs: the Ronald McDonald House®, the Ronald McDonald Family Room® and the Ronald McDonald Care Mobile®. RMHC programs help families with ill or injured children stay together and near leading hospitals and health care services worldwide, ensuring they have access to the medical care their child needs while fully supported and actively involved in their child’s care. For more information, visit rmhc.org. Follow RMHC on Twitter, Facebook, Instagram and LinkedIn.

About RMHC Ireland

The first Irish Ronald McDonald House opened in November 2004 on the grounds of Our Lady’s Hospital, Crumlin, Dublin. Twenty families are cared for every night from across the island of Ireland. Since opening, they have cared for in excess of 4,100 families. RMHC Ireland will continue to care for families at The House in Crumlin until the new hospital and new house open. The expected opening date is 2023. For more information visit www.rmhc.ie.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200910005395/en/

Vertex Pharmaceuticals Incorporated

Investors:

[email protected]

or

+1 617 961 7163



Media:

[email protected]

or

International: +44 7568 611475

U.S.: +1 617 341 6992



Ronald McDonald House Charities

Media:

[email protected]

or

Kristin Hylek: +1 773 547 1018

Source: Vertex Pharmaceuticals Incorporated

Business Wire Press Releases